Comparison of outcome measures during treatment with the proprietary Harpagophytum extract doloteffin in patients with pain in the lower back, knee or hip.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/12046857
Conclusion of this study
About 10% of the patients suffered from minor adverse events that could possibly have been attributable to Doloteffin. Between 50% and 70% of the patients benefitted from Doloteffin with few adverse effects. Thus, Doloteffin is well worth considering for osteoarthritic knee and hip pain and nonspecific low back pain.
Supplements analyzed in this study
Health conditions analyzed in this study
Functions related to this study
Body systems related to this study
